Add to Favorites Newsroom RSS Share
fb-shareJoslin Diabetes Center
Boston, MA USA

Our News on Newswise


Insulin Signaling Failures in the Brain Linked to Alzheimer’s Disease

Scientists continue to find evidence linking Type 2 diabetes with Alzheimer’s disease, the most common form of dementia and the seventh leading cause of death in the United States. However, little is understood about the mechanism by which the two...
13-Mar-2019 12:20 PM EDT Add to Favorites


SGLT-2 inhibitors induce a fasting state that triggers metabolic benefits

Joslin researchers detail how SGLT-2 inhibitors induce a fasting state in the body without requiring the patient to sharply cut back on food intake. This triggers a host of beneficial metabolic effects.
6-Mar-2019 12:05 PM EST Add to Favorites


Protein Released From Fat Following Exercise Improves Glucose Tolerance, and Health

BOSTON – (February 11, 2019) – It’s well-known that exercise improves health, but understanding how it makes you healthier on a molecular level is the question researchers at Joslin Diabetes Center are answering. After performing experiments...
11-Feb-2019 4:50 PM EST Add to Favorites


Is A Continuous Glucose Monitor Right for You?

Every person with diabetes knows that they can make themselves crazy self-testing their blood glucose levels. Continuous glucose monitors (CGMs) are an important tool that can make daily diabetes management a lot easier.
22-Jan-2019 11:30 AM EST Add to Favorites

Study Indicates That Fathers Who Exercise Before Conception Produce Children Who Are Healthier Throughout Their Lives

Recent studies have linked development of type 2 diabetes and impaired metabolic health individuals to their parents’ poor diet, and there is increasing evidence that fathers play an important role in obesity and metabolic programming of their...
22-Oct-2018 10:05 AM EDT Add to Favorites

Using Technology to Manage Type 2 Diabetes Maximizes Time, Resources and Health Outcomes

BOSTON (October 15, 2018) – Harnessing the power of digital health technology --- smart phone apps, telemedicine and mobile health (m-health) --- can provide powerful tools to help people with diabetes self-management, ultimately improving A1c...
15-Oct-2018 10:05 AM EDT Add to Favorites


Changes to RNA may impact growth and function of insulin-producing cells

RNA methylation might prove important in regulating many aspects of beta cell behavior, such as how the cells divide or how effectively they are stimulated by blood glucose to produce insulin
11-Oct-2018 1:05 PM EDT Add to Favorites

Nutrients May Reduce Blood Glucose Levels

BOSTON – (October 10, 2018) – Type 2 diabetes is driven by many metabolic pathways, with some pathways driven by amino acids, the molecular building blocks for proteins. Scientists at Joslin Diabetes Center now have shown that one amino acid,...
10-Oct-2018 2:05 PM EDT Add to Favorites

see all news

Our Experts on Newswise

Diabetes & Breast Cancer - Elizabeth Halprin MD Talks About the Important Struggle to Balance Both Diseases

12-Oct-2017 10:05 AM EDT


Dr. Lori Laffel, Chief of Pediatrics at Joslin Diabetes Center, Available to Comment on Type 1 Diabetes and Life Expectancy Studies

6-Jan-2015 11:00 AM EST


Back to School with Dr. Lori Laffel from Joslin Diabetes Center

Lori Laffel, M.D., MPH, Chief of the Pediatric, Adolescent and Young Adult Section at Joslin Diabetes Center and Associate Professor of Pediatrics at Harvard Medical School, oversees the largest pediatric diabetes clinic in New England has over 25...
15-Aug-2014 8:00 AM EDT

Expert Available: Bariatric Surgery for Diabetes

The International Diabetes Federation now recommends that surgery be considered as a treatment for obese patients with type 2 diabetes. Dr. Allison Goldfine, head of clinical research at Joslin Diabetes Center, is available for comment.
29-Mar-2011 9:00 AM EDT

see all experts

Our YouTube Videos


Joslin Diabetes Center is world-renowned for its deep expertise in diabetes treatment and research. Joslin is dedicated to finding a cure for diabetes and ensuring that people with diabetes live long, healthy lives. We develop and disseminate innovative patient therapies and scientific discoveries throughout the world. Joslin is an independent, non-profit institution affiliated with Harvard Medical School, and one of only 11 NIH-designated Diabetes Research Centers in the U.S.

For more information, visit or follow @joslindiabetes


Jeffrey Bright
Director, Communications


Twitter twitter-icon

Chat now!